Topical gel formulation of broadly neutralizing anti-HIV-1 monoclonal antibody VRC01 confers protection against HIV-1 vaginal challenge in a humanized mouse model

Por Veselinovic, Milena, Preston Neff, C., Mulder, Leila R., Akkina, Ramesh
Publicado em 2012